CN107778338A - A kind of rebaudioside C isolation and purification methods - Google Patents

A kind of rebaudioside C isolation and purification methods Download PDF

Info

Publication number
CN107778338A
CN107778338A CN201610190936.4A CN201610190936A CN107778338A CN 107778338 A CN107778338 A CN 107778338A CN 201610190936 A CN201610190936 A CN 201610190936A CN 107778338 A CN107778338 A CN 107778338A
Authority
CN
China
Prior art keywords
rebaudioside
isolation
purification methods
solution
methods according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610190936.4A
Other languages
Chinese (zh)
Inventor
刘建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stillwell Biological Technology (suzhou) Co Ltd
Original Assignee
Stillwell Biological Technology (suzhou) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stillwell Biological Technology (suzhou) Co Ltd filed Critical Stillwell Biological Technology (suzhou) Co Ltd
Priority to CN201610190936.4A priority Critical patent/CN107778338A/en
Publication of CN107778338A publication Critical patent/CN107778338A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/256Polyterpene radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention discloses a kind of rebaudioside C isolation and purification methods, by using suitable process-scale chromatography post and solution, and optimize technique step, with high performance liquid chromatography detection, rebaudioside C is obtained from Stevioside raw material with reference to the method for column chromatography for separation and recrystallization, cost is low more economical, and purity is high, yield is high, and purity is more than 95%, and yield is more than 60%.

Description

A kind of rebaudioside C isolation and purification methods
Technical field
The present invention relates to a kind of rebaudioside C isolation and purification methods.
Background technology
Stevioside has been used more than 20 years in Asia as sweetener.2008, North America by ratify its as Food additives.Therefore, stevioside and its effective purification process are that have very high business demand.It is main in STEVIA REBAUDIANA The stevioside wanted includes Stevioside, rebaudioside C, content rebaudioside-A and rebaudioside D.Rebaudioside D and rebaudioside C Sub-fraction therein is only account for, but they have purer sweet taste and unique application, thus there is higher business Industry is worth.The isolation and purification method on content rebaudioside-A and stevioside has much in the prior art, to rebaudioside C's Concern is seldom.
There is research to point out, although rebaudioside C bitter tastes are heavier, there is antitumor, lowering blood pressure and blood fat, fat-reducing etc. Many effects, its potential using value have a great attraction.Therefore there is an urgent need to one kind can high-purity, high yield separation and it is pure Change rebaudioside C method.
The content of the invention
The present invention is to solve the defects of prior art, there is provided a kind of rebaudioside C isolation and purification methods.For in solution Technical problem is stated, the technical solution adopted by the present invention is:
A kind of rebaudioside C isolation and purification methods, comprise the following steps:
(1) raw material stevioside is dissolved in 3 times of amount deionized waters, then concentrated aqueous liquid to the 50% of about original volume, Sample is made, above-mentioned sample is pumped into the process-scale chromatography column top for being filled with resinous polymer by (2), is mixed with water/acetone or acetonitrile Solution gradient elutes, and the concentration gradient of the water and acetone/acetonitrile mixed solution is molten for 5%-35% water/acetone or acetonitrile Liquid, the concentration gradient are percent by volume;
(3) the elution solution that Fractional Collections elutes from resinous polymer chromatographic column, then uses high-efficient liquid phase color respectively Spectrum analysis detection, after rebaudioside C is all eluted in sample, stops elution, and chromatographic column continues to use pure water rinsing, balances Pillar is in case reuse;
(4) the elution solution containing higher degree rebaudioside C in step (3) after analysis detects is passed through into NF membrane Proper volume (solid contents is between 15-20%) is concentrated into, concentrate continues further to be concentrated with single-effect vacuum inspissator To medicinal extract shape (ratio weighs about 1.13-1.15), medicinal extract is spray-dried to obtain rebaudioside C raw material dry powder.
5) above-mentioned dry powder is dissolved in aqueous acetone and is heated to all solids and is completely dissolved, then added equivalent to solution 2-3 times of acetone of volume, obtained mixed solution is stirred into more than 12h in 20-30 DEG C, finally obtains white crystal, mistake Filter, dry rebaudioside C semi-finished product.
(6) above-mentioned semi-finished product are added in appropriate aqueous methanol, then heat to 55-60 DEG C it is completely molten to all solids Solution temperature, is then down to and is stored at room temperature 5 hours, obtained white crystal is filtered out by solution.
(7) white crystal obtained in step (6) is placed at 70-80 DEG C and be dried in vacuo, finally use high performance liquid chromatography Analyze dried crystalline content;
The resinous polymer is polystyrene/divinylbenzene polymer.Such as the CG-161m series plastics of ROHM AND HAAS Or similar resin.
Preferably, the above-mentioned alleged equipment that eluent concentration is used is the nanofiltration film condensing device that molecular weight is 150..
Preferably, the weight of resinous polymer is 4-20 times of Stevioside weight in step (1) in step (2).
The beneficial effect that the present invention is reached:
The production method of the present invention can obtain rebaudioside C from stevioside raw material, and cost is low more economical, and purity Height, yield is high, and purity is more than 95%, and yield is more than 60%.
Purity detecting, and production are carried out to the product of separation process all the time using HPLC analytical method in the present invention Thing rebaudioside C and stevioside determination, high performance liquid chromatography detection equipment are by Shimadzu LC-10A systems and Shimadzu SPD- 10A multiwavelength detectors form, and pillar is 250mm*4.6mm i.d.5 μm C18 posts, what 32% acetonitrile and 68% water formed Isocratic mobile phase, flow velocity 1.0ml/min, Detection wavelength 210nm, stevioside and rebaudioside C are quantified with reference substance.
Brief description of the drawings
Fig. 1 is the rebaudioside C high-efficient liquid phase chromatograms that the present invention isolates and purifies;
Fig. 2 production Technology route maps.
Embodiment
The invention will be further described below in conjunction with the accompanying drawings.Following examples are only used for clearly illustrating the present invention Technical scheme, and can not be limited the scope of the invention with this.
Embodiment one
(1) C containing rebaudioside 15.2% raw material stevioside 50kg is added in 500L reactors, then added 150L deionized waters and stir be warming up to 70 DEG C, after solids is completely dissolved, this solution is released and is pumped into from reactor The 50% of about original volume is concentrated into haplo-effect concentrator, sample is made.
(2) above-mentioned sample is pumped directly into and be filled with the top of the industrially prepared chromatographic column of resinous polymer, resinous polymer Weight is 10 times of Stevioside weight in step (1).With water and the mixed solution gradient elution of acetone, the water mixes with acetone The concentration gradient of solution is 10%-35% (volume ratio)
(3) the elution solution that Fractional Collections elutes from resinous polymer chromatographic column, then uses high-efficient liquid phase color respectively Spectrum analysis detection, after rebaudioside C is all eluted in sample, stops elution.
(4) the elution solution containing higher degree rebaudioside C in step (3) after analysis detects is passed through into NF membrane Device concentrate, it is to be concentrated to about original volume 20% when stop, concentrate is transferred to single-effect vacuum inspissator and is further concentrated into leaching Paste (proportion 1.13-1.15), this medicinal extract must further contain rebaudioside C 35-45% Lai Baodi with spray dryer spray drying Glucoside C raw materials for production.5) above-mentioned dry powder is dissolved in aqueous acetone and is heated to all solids and is completely dissolved, then add equivalent to 2-3 times of acetone of liquor capacity, obtained mixed solution is stirred into more than 12h in 20-30 DEG C, finally obtain white crystalline substance Body, filtering, dry rebaudioside C semi-finished product.
(6) above-mentioned semi-finished product are added in appropriate aqueous methanol, then heat to 55-60 DEG C it is completely molten to all solids Solution temperature, is then down to and is stored at room temperature 5 hours, obtained white crystal is filtered out by solution.
(7) white crystal obtained in step (6) is placed at 80 DEG C and be dried in vacuo, finally use efficient liquid phase chromatographic analysis Dried crystalline content;The crystal is rebaudioside C, purity 95.3%, weight 4.65kg, yield 61%.
Resinous polymer alleged by above is ROHM AND HAAS Amberlite 1600
Embodiment two
Target material:60kg steviosides, wherein purchase gained, Stevioside 24%, content rebaudioside-A 27%, rebaudioside C15.5%, surplus are impurity.
Chromatographic column:High pressure industrial prepares layer post, column dimensions 800*3000mm, filling 1000L Rohm HaasAmberlite1600。
Experimental procedure:
(1) C containing rebaudioside 15.5% raw material stevioside 60kg is added in 500L reactors, then added 180L deionized waters and stir be warming up to 75 DEG C, after solids is completely dissolved, this solution is released and is pumped into from reactor The 50% of about original volume is concentrated into haplo-effect concentrator, sample is made.
(2) above-mentioned sample is pumped directly into and be filled with the top of the industrially prepared chromatographic column of resinous polymer, resinous polymer Weight is 8 times of Stevioside weight in step (1).With water and the mixed solution gradient elution of acetone, the water mixes with acetone The concentration gradient of solution is 10%-35% (volume ratio)
(3) the elution solution that Fractional Collections elutes from resinous polymer chromatographic column, then uses high-efficient liquid phase color respectively Spectrum analysis detection, after rebaudioside C is all eluted in sample, stops elution.
(4) the elution solution containing higher degree rebaudioside C in step (3) after analysis detects is passed through into NF membrane Device concentrate, it is to be concentrated to about original volume 20% when stop, concentrate is transferred to single-effect vacuum inspissator and is further concentrated into leaching Paste (proportion 1.13-1.15), this medicinal extract must further contain rebaudioside C 35-45% Lai Baodi with spray dryer spray drying Glucoside C raw materials for production.
(5) above-mentioned dry powder is dissolved in aqueous acetone and is heated to all solids and is completely dissolved, then added equivalent to molten 2-3 times of acetone of liquid product, stirs more than 12h by obtained mixed solution in 20-30 DEG C, finally obtains white crystal, Filtering, dry rebaudioside C semi-finished product.
(6) above-mentioned semi-finished product are added in appropriate aqueous methanol, then heat to 55-60 DEG C it is completely molten to all solids Solution temperature, is then down to and is stored at room temperature 5 hours, obtained white crystal is filtered out by solution.
(7) white crystal obtained in step (6) is placed at 80 DEG C and be dried in vacuo, finally use efficient liquid phase chromatographic analysis Dried crystalline content;The crystal is rebaudioside C, purity 95.5%, weight 5.76kg, yield 62%.
The high performance liquid chromatography spectrogram of stevioside and rebaudioside C after isolating and purifying above is shown in Fig. 1.
Described above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art For member, without departing from the technical principles of the invention, some improvement and deformation can also be made, these are improved and deformation Also it should be regarded as protection scope of the present invention.

Claims (8)

1. a kind of rebaudioside C isolation and purification methods, it is characterised in that comprise the following steps:
(1) raw material Stevioside is added in the deionized water of triplication, is then heated to 70 DEG C and is completely dissolved to all solids, so Obtained solution is concentrated into small size afterwards sample is made, above-mentioned sample is pumped into the process-scale chromatography for being filled with resinous polymer by (2) Column top, with water and acetone/acetonitrile mixed solution gradient elution, the water and the concentration gradient of acetone/acetonitrile mixed solution are 5%-35% water and acetone/acetonitrile solution, the concentration gradient is volume % ratios;
(3) the elution solution that Fractional Collections elutes from resinous polymer chromatographic column, then respectively with high performance liquid chromatography point Analysis detection, after rebaudioside C is all eluted in sample, stop elution;
(4) it is the elution solution containing high content rebaudioside C fractions in step (3) after analysis detects is dense by NF membrane Proper volume (solid contents is between 15-20%) is reduced to, concentrate is further concentrated into medicinal extract with single-effect vacuum inspissator Shape (ratio weighs about 1.13-1.15), medicinal extract are spray-dried to obtain rebaudioside C raw material dry powder;
(5) above-mentioned dry powder is dissolved in aqueous acetone and is heated to all solids and is completely dissolved, then added equivalent to solution body 2-3 times long-pending of acetone, obtained mixed solution is stirred into more than 12h in 20-30 DEG C, finally obtains white crystal, filtered, Dry rebaudioside C semi-finished product;
(6) above-mentioned semi-finished product are added in appropriate aqueous methanol, then heat to 55-60 DEG C and be completely dissolved to all solids, with Solution temperature is down to afterwards and is stored at room temperature 5 hours, obtained white crystal is filtered out;
(7) white crystal obtained in step (6) is placed at 70-80 DEG C and be dried in vacuo, finally use efficient liquid phase chromatographic analysis Dried crystalline content.
2. a kind of rebaudioside C isolation and purification methods according to claim 1, it is characterised in that use nano filter membrance device Eluent is reclaimed into reuse repeatedly.
3. a kind of rebaudioside C isolation and purification methods according to claim 1, it is characterised in that used in concentrated liquid Equipment is single-effect vacuum ager.
A kind of 4. rebaudioside C isolation and purification methods according to claim 1, it is characterised in that the resinous polymer For polystyrene/divinylbenzene polymer.
5. a kind of rebaudioside C isolation and purification methods according to claim 1, it is characterised in that during the chromatographic column is High pressure industrial preparative separation chromatographic column.
A kind of 6. rebaudioside C isolation and purification methods according to claim 5, it is characterised in that the mesohigh industry The operating pressure of preparative separation chromatographic column is 1.5-3.0Mpa.
A kind of 7. rebaudioside C isolation and purification methods according to claim 1, it is characterised in that the column Mobile The elution flow rate of phase is 2-5 bed volume (2-5BV)/h per hour.
8. a kind of rebaudioside C isolation and purification methods according to claim 1, it is characterised in that resin gathers in step (2) The weight of compound is 4-20 times of Stevioside weight in step (1).
CN201610190936.4A 2016-08-29 2016-08-29 A kind of rebaudioside C isolation and purification methods Pending CN107778338A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610190936.4A CN107778338A (en) 2016-08-29 2016-08-29 A kind of rebaudioside C isolation and purification methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610190936.4A CN107778338A (en) 2016-08-29 2016-08-29 A kind of rebaudioside C isolation and purification methods

Publications (1)

Publication Number Publication Date
CN107778338A true CN107778338A (en) 2018-03-09

Family

ID=61387707

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610190936.4A Pending CN107778338A (en) 2016-08-29 2016-08-29 A kind of rebaudioside C isolation and purification methods

Country Status (1)

Country Link
CN (1) CN107778338A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108530503A (en) * 2018-05-17 2018-09-14 苏州赛分科技有限公司 A kind of isolation and purification method of dulcoside B
CN111440220A (en) * 2020-05-09 2020-07-24 浙江天草生物科技股份有限公司 Method for preparing high-purity stevioside RC from mother liquor sugar
CN112480127A (en) * 2020-12-11 2021-03-12 无锡福祈制药有限公司 Novel method for producing mitomycin

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101628924A (en) * 2009-08-21 2010-01-20 天津美伦医药集团有限公司 Process for extracting rebaudioside C in stevioside
CN102030788A (en) * 2011-01-05 2011-04-27 沈阳天峰生物制药有限公司 Method for preparing rebaudioside C
CN102127130A (en) * 2011-01-14 2011-07-20 青岛润浩甜菊糖高科有限公司 Purification method of stevioside RC (rebaudioside C)
CN103122015A (en) * 2011-11-18 2013-05-29 国际香料和香精公司 Method for purifying rebaudioside c
CN103965271A (en) * 2013-01-25 2014-08-06 沈阳天峰生物制药有限公司 Method for preparing rebaudioside C from stevia sugar

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101628924A (en) * 2009-08-21 2010-01-20 天津美伦医药集团有限公司 Process for extracting rebaudioside C in stevioside
CN102030788A (en) * 2011-01-05 2011-04-27 沈阳天峰生物制药有限公司 Method for preparing rebaudioside C
CN102127130A (en) * 2011-01-14 2011-07-20 青岛润浩甜菊糖高科有限公司 Purification method of stevioside RC (rebaudioside C)
CN103122015A (en) * 2011-11-18 2013-05-29 国际香料和香精公司 Method for purifying rebaudioside c
CN103965271A (en) * 2013-01-25 2014-08-06 沈阳天峰生物制药有限公司 Method for preparing rebaudioside C from stevia sugar

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108530503A (en) * 2018-05-17 2018-09-14 苏州赛分科技有限公司 A kind of isolation and purification method of dulcoside B
CN108530503B (en) * 2018-05-17 2021-05-07 苏州赛分科技有限公司 Method for separating and purifying rebaudioside C
CN111440220A (en) * 2020-05-09 2020-07-24 浙江天草生物科技股份有限公司 Method for preparing high-purity stevioside RC from mother liquor sugar
CN111440220B (en) * 2020-05-09 2023-05-05 浙江天草生物科技股份有限公司 Method for preparing high-purity stevioside RC from mother liquor sugar
CN112480127A (en) * 2020-12-11 2021-03-12 无锡福祈制药有限公司 Novel method for producing mitomycin

Similar Documents

Publication Publication Date Title
CN103408602B (en) A kind of method being separated preparation four kinds of glycoside chemical reference substances from ZANGYINCHEN
CN107778338A (en) A kind of rebaudioside C isolation and purification methods
CN105566414B (en) The method that four kinds of flavone glycosides are isolated and purified from waxberry flesh
WO2016082122A1 (en) Preparation method for medicinal chlorogenic acid
CN104892717B (en) A kind of technical grade preparative liquid chromatography separation method of momordica glycoside V
CN107098942A (en) A kind of method of kaempferia galamga glycosides in Subcritical Water Extraction radish leaves
CN107674116A (en) A kind of purification process of Pneumocandin B0
CN107936033A (en) The method that industrially prepared liquid chromatogram isolates and purifies koumine
CN108003211A (en) A kind of method of quick separating ganoderic acid in accessory substance from ganoderma lucidum
CN100434148C (en) Process for separating and purifying organic compound by macroporous absorption resin-reverse osmosis membrane
CN104628801A (en) Process for extracting and separating linarin from wild chrysanthemum
CN105017367B (en) A kind of method separating lanosterol and lanostenol
CN103265521A (en) Preparation method of demethylated beilidifolin
CN104961716B (en) Method for separating high-purity lactone type lovastatin from fermentum rubrum powder
CN104844550B (en) A kind of method that osthole and imperatorin are isolated and purified from Fructus Cnidii
CN104844547B (en) A kind of high efficiency extraction of barbaloin and grading purification method
CN108373474B (en) A bilobalide compound extracted from folium Ginkgo and its preparation method
CN105820213B (en) The method for efficiently separating purifying knob not Kangding
CN107382943B (en) Method for subcritical water extraction of dihydroquercetin in sorghum bran
CN102276570B (en) Method for purifying epigallo catechin gallate (EGCG)
CN102503998B (en) Method for rapidly separating quercetin from flos albiziae
CN105037452B (en) A kind of process for purification of quick preparation high-purity Fondaparinux sodium
CN106008441B (en) A kind of purification process of high-purity EGC
CN101353294A (en) Separation and purification method of high-content resveratrol
CN103408616A (en) Preparation method of Brucea javanica glucoside A

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Patents of Stilwell Biotechnology (Suzhou) Co.,Ltd. The person in charge

Document name: Deemed notice of withdrawal

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180309